These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 22664222)

  • 41. The worldwide impact of the seven-valent pneumococcal conjugate vaccine.
    Fitzwater SP; Chandran A; Santosham M; Johnson HL
    Pediatr Infect Dis J; 2012 May; 31(5):501-8. PubMed ID: 22327872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.
    Li ST; Tancredi DJ
    Pediatrics; 2010 Jan; 125(1):26-33. PubMed ID: 19948570
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review.
    Myint TT; Madhava H; Balmer P; Christopoulou D; Attal S; Menegas D; Sprenger R; Bonnet E
    Adv Ther; 2013 Feb; 30(2):127-51. PubMed ID: 23397399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pneumonia hospitalizations of children aged <2 years in Poland before (2013-2016) and after (2017-2018) universal mass vaccination with 10-valent pneumococcal non-typeable
    Bhavsar A; Zaryczański J; Wasilewska A; Saragoussi D; Devadiga R; Colby C; Bahar E; Wysocki J
    Hum Vaccin Immunother; 2022 Nov; 18(6):2128566. PubMed ID: 36239615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significant impact of pneumococcal conjugate vaccination on pediatric parapneumonic effusion: Italy 2006-2018.
    Azzari C; Serranti D; Nieddu F; Moriondo M; Casini A; Lodi L; de Benedictis FM; De Vitis E; Cavone F; Cortimiglia M; Indolfi G; Lombardi E; Carloni I; Cutrera R; Lucenteforte E; Resti M; Ricci S
    Vaccine; 2019 May; 37(20):2704-2711. PubMed ID: 30981627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pneumococcal invasive disease in newborns before and after 7-valent and 13-valent universal pneumococcal vaccination in Uruguay].
    Assandri E; Amorín B; Gesuele JP; Algorta G; Pírez MC
    Rev Chilena Infectol; 2015 Apr; 32(2):167-74. PubMed ID: 26065449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain.
    Benito-Fernández J; Raso SM; Pocheville-Gurutzeta I; SánchezEtxaniz J; Azcunaga-Santibañez B; Capapé-Zache S
    Pediatr Infect Dis J; 2007 Aug; 26(8):667-71. PubMed ID: 17848875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.
    Rudnick W; Liu Z; Shigayeva A; Low DE; Green K; Plevneshi A; Devlin R; Downey J; Katz K; Kitai I; Krajden S; Ostrowska K; Richardson D; Richardson S; Sarabia A; Silverman M; Simor AE; Tyrrell G; McGeer A;
    Vaccine; 2013 Dec; 31(49):5863-71. PubMed ID: 24099873
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improving the protection against Streptococcus pneumoniae with the new generation 13-valent pneumococcal conjugate vaccine.
    Durando P; Alicino C; De Florentiis D; Martini M; Icardi G
    J Prev Med Hyg; 2012 Jun; 53(2):68-77. PubMed ID: 23240163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
    Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
    Hsu KK; Shea KM; Stevenson AE; Pelton SI;
    Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia.
    Burgos J; Falcó V; Borrego A; Sordé R; Larrosa MN; Martinez X; Planes AM; Sánchez A; Palomar M; Rello J; Pahissa A
    Clin Microbiol Infect; 2013 Apr; 19(4):385-91. PubMed ID: 22583156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. All-cause pneumonia hospitalizations in children <2 years old in sweden, 1998 to 2012: impact of pneumococcal conjugate vaccine introduction.
    Berglund A; Ekelund M; Fletcher MA; Nyman L
    PLoS One; 2014; 9(11):e112211. PubMed ID: 25379659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors for nasopharyngeal carriage of Streptococcus pneumoniae in healthy Turkish children after the addition of heptavalent pneumococcal conjugate vaccine (PCV7) to the national vaccine schedule.
    Özdemir H; Çiftçi E; Durmaz R; Güriz H; Aysev AD; Karbuz A; Gökdemir R; Acar B; Nar-Ötgün S; Ertek M; Köse SK; İnce E
    Turk J Pediatr; 2013; 55(6):575-83. PubMed ID: 24577974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine--United States, 1997-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jan; 58(1):1-4. PubMed ID: 19145219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
    Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pneumonia in Elderly Australians: Reduction in Presumptive Pneumococcal Hospitalizations but No Change in All-Cause Pneumonia Hospitalizations Following 7-Valent Pneumococcal Conjugate Vaccination.
    Menzies RI; Jardine A; McIntyre PB
    Clin Infect Dis; 2015 Sep; 61(6):927-33. PubMed ID: 26066319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States.
    Zhou F; Kyaw MH; Shefer A; Winston CA; Nuorti JP
    Arch Pediatr Adolesc Med; 2007 Dec; 161(12):1162-8. PubMed ID: 18056561
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
    Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR
    Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.